Last edition
News about "ORLADEYO "
Pint Pharma Announces Approval of ORLADEYO in Peru
Pint Pharma has announced that the General Directorate of Medicines Supplies and Drugs (DIGEMID) in Peru has announced the approval of ORLADEYO (berotralstat) for prophylaxis of hereditary angioedema (HAE) attacks in adults and children 12 years and older.
ORLADEYO | 10/07/2024 | By Aishwarya | 245
BioCryst Announces Approval of ORLADEYO from Brazilian Health Regulatory Agency
BioCryst Pharmaceuticals has announced that the Brazilian Health Regulatory Agency (ANVISA) has granted approval for oral, once-daily ORLADEYO (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks in adults.
ORLADEYO | 20/04/2024 | By Aishwarya | 192
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy